Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2026
Fortrea completes acquisition of Worldwide Clinical Trials’ Early Phase Services division
Fortrea completed its approximately $45 million all-cash acquisition of the Early Phase Services division from Worldwide Clinical Trials. The acquired division includes clinical research unit and bioanalytical laboratory operations.
2021
Psilera contracts Worldwide Clinical Trials for pre-IND work
Psilera entered a consulting contract with Worldwide Clinical Trials to support pre-IND milestones for Psilera's patent-pending DMT patch.